Thursday, April 2, 2020

Trial drug can significantly block early stages of COVID-19 in engineered human tissues

An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200402144526.htm
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)